| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.41 | 0.007 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |